查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829582

术中 MRI 市场（按场强、扫描仪类型、系统类型、应用和最终用户）—2025-2032 年全球预测

Intraoperative MRI Market by Field Strength, Scanner Type, System Type, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，术中 MRI 市场将成长 48 亿美元，复合年增长率为 12.59%。

主要市场统计数据
基准年2024年 18.6亿美元
预计2025年 20.9亿美元
预测年份：2032年 48亿美元
复合年增长率（%） 12.59%

关于术中 MRI 的演变、临床驱动因素以及影响其在现代外科手术项目中应用的整合挑战的权威概述

术中磁振造影(MRI) 已从一种新兴的辅助手段发展成为重塑手术精准度和手术全期决策的重要工具。本介绍将阐述临床、技术和组织驱动因素如何融合，加速其在各专科实务中的应用。磁铁设计、影像序列以及与外科工作流程整合的进步，使团队能够在维持功能的同时，确认手术切缘，最大限度地减少再次手术，并降低併发症发生率。同时，低场硬体、行动解决方案以及与手术器械相容性的提升，正在扩展可纳入即时影像的手术范围。

临床医生、医院管理人员和设备规划人员面临更复杂的局面，需要协调临床效果、营运约束和员工能力。报销制度和实证前瞻性研究正在影响机构的投资意愿，而技术供应商则以模组化系统和服务模式应对，这些模式强调工作流程的整合和培训。因此，术中MRI的发展历程是务实的创新。虽然这项技术正在逐渐成熟，成为能够满足临床需求的实用解决方案，但成功的部署需要多学科协作、强有力的变革管理以及明确的以患者为中心的价值衡量标准。

技术整合、工作流程整合和临床证据正在推动术中 MRI 采用和实践的根本性重塑。

由于技术创新、临床证据的不断累积以及医疗服务模式的不断变化，术中 MRI 的前景正在改变。磁铁工程和影像处理软体的最新进展降低了术中应用的门槛，使得高保真、高场解决方案和灵活的低场系统能够适应各种手术环境。同时，移动式和固定式系统设计的出现，使医疗机构能够根据其手术量和机构限制调整资本投资。这些硬体创新与改进的成像序列和术中方案相辅相成，这些方案增强了组织对比度，减少了伪影，并缩短了采集时间，使术中 MRI 能够更好地适应手术节奏。

不仅是硬件，以工作流程为中心的发展，例如与神经导航平台、设备追踪技术和术中计划工具的集成，正在将价值提案从单纯的图像采集转变为全面的术中决策支援。同时，术中MRI的临床证据也日益丰富，尤其是在神经外科肿瘤切除术以及整形外科和肿瘤科的应用领域。这些证据正在催生新的医疗途径，优先考虑单阶段确定性手术而非分阶段介入。最后，供应商正在响应这一趋势，推出强调培训、远端支援和结果监测的服务模式，进一步降低实施风险，并增强临床医生对术中MRI的信心。

2025 年美国关税对术中 MRI 专案采购、供应链弹性和业务连续性的连锁反应

随着全球供应链和贸易政策的演变，美国将于2025年征收关税，已成为涉及术中成像解决方案的製造商、经销商和医疗保健系统的关键因素。这些关税措施对核心零件的采购计算产生了重大影响，这些零件通常在多个司法管辖区生产，例如超导性材料、专用梯度和某些电子子系统。为此，供应商不得不重新评估筹资策略，选择替代供应商，在某些情况下，还要重新设计零件以减轻受影响关税细则的影响。由于供应链被重新检验并实施双重采购方案，这导致生产前置作业时间在短期内增加。

随着资本采购週期调整以适应更长的前置作业时间和不断变化的交货计划，临床医生和医院采购团队已经观察到了下游影响。因此，医疗保健机构优先考虑策略采购计划，并与供应商密切合作，以确保交付时间和透明的零件采购。同时，製造商尽可能加快本地化和国内组装速度，以最大限度地降低关税影响并提供更具弹性的交货承诺。这些营运转变也影响了服务合约和备件物流，迫使医疗保健系统重新评估生命週期支援协议，以确保护理的连续性，并最大限度地降低关键手术期间设备停机的风险。

细分级别的洞察揭示了场强、扫描器架构、系统移动性、临床应用和最终用户偏好如何决定技术选择和临床工作流程

对系统细分的细緻理解，有助于明确临床需求与技术能力和采购偏好的交会点。低场平台占地面积更小，屏蔽要求更简单，并与现有手术室基础设施的兼容性更高。封闭式设计与开孔设计会影响病患入路与术中人体工学。封闭式设计通常可为头部和部分身体手术提供稳定的影像质量，而开孔设计则更易于手术入路和成像过程中的病患监测。

依系统类型进一步细分，可区分移动系统和固定係统，这是一个影响资本配置、房间转换需求和调度灵活性的关键营运维度。对于希望在不改造永久病房的情况下将影像处理功能分配到多个病房的医疗机构而言，移动系统是一个相当有吸引力的选择；而固定係统则通常被注重影像保真度和一体化手术室设计的高容量医疗中心所选择。按应用领域划分，术中磁振造影 (MRI) 用于心血管外科、神经外科、肿瘤外科和整形外科手术，其中神经外科进一步分为开颅手术和脊椎外科，每种手术都反映了不同的影像处理和工作流程要求。最后，以最终用户划分，门诊手术中心和医院的采用路径不同：医院通常会投资于支持复杂、多学科病例的综合项目，而门诊手术中心则更倾向于选择经济高效、精简的系统，以适应高通量择期手术。

亚太地区、欧洲和中东/非洲的区域动态和基础设施现状塑造了术中 MRI 的采用途径和支持模式

区域动态对监管路径、采购行为和临床应用模式有重大影响。在美洲，成熟的神经外科专科中心和综合医疗体係正在推动复杂脑肿瘤切除术和先进术中通讯协定的早期应用，这得益于密集的转诊网络和密集的研究活动。该地区对模组化服务结构和资金筹措模式的需求也十分强劲，这些模式旨在将资本投资与营运吞吐量和临床结果预期相匹配。

在欧洲、中东和非洲，机构多样性推动了多样化的采用模式。先进的三级医疗中心追求高场强固定设备，以支援尖端的神经外科项目，而资源受限的中心则评估低场强或移动式方案，以平衡临床效益与基础设施和人员配备方面的考虑。监管协调和跨境临床合作正在进一步影响采购决策週期和证据生成工作。在亚太地区，手术能力的快速扩张、医院现代化程度的提高以及对专科护理的定向投资，正在推动人们对移动和固定解决方案的兴趣，并重点关注扩充性、服务可靠性和本地支持网络。在全部区域，本地培训计划、报销框架和供应链考量对于决定术中磁振造影的采用速度和形态至关重要。

竞争和服务驱动因素再形成术中 MRI 生态系统中的供应商策略、整合模型和临床伙伴关係

竞争格局由少数老牌製造商、新兴专业供应商以及专注于整合、培训和生命週期支援的服务供应商所构成。现有的技术供应商继续利用其深厚的工程专业知识和临床伙伴关係关係，提供全面的服务包，以扩展模组化、改进成像序列并降低部署和操作过程中的机构风险。同时，专业领域的参与企业则透过强调移动性、降低屏蔽要求和简化使用者介面的设计选择来脱颖而出，从而降低了手术室团队将术中成像纳入日常工作流程的门槛。

服务合作伙伴和系统整合商透过提供计划管理、培训和结果监控方案，将产品功能转化为可靠的临床表现，发挥日益重要的作用。供应商和临床中心之间的合作促成了标准化协议和共用资料集的诞生，从而传达了最佳实践。保固和远端支援模式也在不断发展，以确保运作和快速解决问题。同时，规模较小的医疗机构更注重灵活性、整体拥有成本和供应商的应对力。这些趋势凸显了供应商需要将强大的技术产品与强大的商业性和临床支援能力结合。

为医疗保健领导者提供可行的营运和策略建议，以优化术中 MRI 技术的选择、实施、培训和结果测量

产业领导者和医院管理人员可以采取具体行动，确保术中MRI的成功部署并最大化临床效益。首先，在计划规划初期协调临床相关人员，明确病例组合、工作流程目标和培训要求，确保技术选择由手术需求而非供应商的说服力驱动。其次，优先制定筹资策略，该策略应包含生命週期支援、备件供应和明确的服务等级协议，以遵守手术计划并确保可预测的正常执行时间。第三，考虑混合部署模式，将用于分散存取的行动系统与用于复杂病例的集中式固定单元相结合，从而优化资本配置和临床覆盖范围。

第四，投资结构化培训计画和基于模拟的认证，以缩短临床医生的学习曲线，并将影像学通讯协定纳入常规实践。第五，建立一个结果监测框架，追踪关键临床指标，例如再次手术率、手术时间和以患者为中心的功能结果，并利用这些数据改进通讯协定，并证明持续投资的合理性。最后，与供应商保持密切合作，共同开发影像学方案、手术室人体工学以及与导航和手术计划工具整合方面的渐进式改进，确保技术发展与临床优先事项和操作限制紧密结合。

一种透明的、以证据为导向的研究途径，整合临床文献、技术文件和相关人员访谈，为决策者提供可行的见解

本执行摘要所依据的研究综合，是对同侪审查的临床研究、技术白皮书、监管备案文件和供应商产品文件的结构化回顾，并辅以对临床主任、采购专家和系统整合商的定性访谈。资讯经过跨多个独立资讯来源的三角整合，以形成关于技术趋势、应用驱动因素和营运挑战的连贯叙述。我们强调纵向临床证据和实际实施经验，以确保这些见解是基于实际实施的实际情况，而非行销标语。

我们运用严谨的分析方法，解读设备设计特性、工作流程影响和供应链漏洞，并关注各种用例，包括神经外科、肿瘤科、整形外科和心血管外科。我们仔细考虑了区域监管环境和采购惯例，并关注临床有效性与操作可行性之间的相互作用。在直接比较资料有限的情况下，我们运用定性专家判断来综合评估专案结果的可能性，所有结论均优先考虑基础假设和资料来源的可重复性和透明度。

综合结论强调了成功的术中 MRI 计划的临床价值、实施要求和操作前提

总而言之，术中MRI在优先考虑单阶段确定性介入措施和卓越组织保留结果的外科手术计画中发挥着日益重要的作用。包括场强、扫描器架构和系统移动性等多功能性在内的技术创新，正在扩展术中成像实用且有益的临床应用场景。同时，各关键专业领域日益成熟的证据正在明确术中MRI的临床益处，促使更多医疗保健领导者将这种成像方式作为对卓越外科手术策略投资的一部分进行评估。

成功的实施不仅取决于设备性能；它需要临床团队、采购和服务合作伙伴的全面规划，以及持续的培训和结果评估。供应链和贸易政策的製定需要积极的采购规划和强大的供应商伙伴关係关係，以确保服务的连续性。最终，那些能够将临床目标与技术选择、训练投资和结果监测巧妙地结合的机构，将最有能力将术中MRI功能转化为对患者和系统可证明的价值。

目录

第一章 引言

第二章分析方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 将人工智慧整合到术中 MRI 工作流程中，实现即时影像分析
  • 开发7特斯拉超高磁场系统，提升手术精准度
  • 扩展我们用于门诊和混合手术室的可携式低场术中 MRI 设备产品组合
  • 影像设备製造商与机器人手术公司建立策略联盟，共同打造整合式 iMRI 解决方案
  • 成本效率和工作流程优化在术中 MRI 采用和报销模式中的重要性日益增加
  • 监管核准和安全指南推动新型术中 MRI造影剂和通讯协定的开发
  • 功能性神经外科中的新型术中 MRI 应用可实现大脑网路的即时映射

第六章：美国关税的累积影响（2025年）

第七章：人工智慧（AI）的累积影响（2025年）

第 8 章术中 MRI 市场：依磁场强度

  • 高磁场
  • 低磁场

第九章：术中 MRI 市场（依扫描器类型）

  • 闭孔
  • 开膛

第 10 章。按系统类型分類的术中 MRI 市场

  • 可移动系统
  • 固定係统

第 11 章术中 MRI 市场：依应用

  • 心血管系统
  • 神经外科
    • 开颅手术
    • 脊椎手术
  • 瘤
    • 切片检查指导
    • 肿瘤切除术
  • 整形外科

第 12 章术中 MRI 市场（依最终用户划分）

  • 门诊手术中心
  • 医院

第十三章 术中 MRI 市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第 14 章。按组别分類的术中 MRI 市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 15 章。按国家/地区分類的术中 MRI 市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章竞争格局

  • 市占率分析（2024年）
  • FPNV定位矩阵（2024年）
  • 竞争分析
    • Siemens Healthineers AG
    • GE HealthCare Technologies Inc.
    • Koninklijke Philips NV
    • Hitachi, Ltd.
    • Canon Medical Systems Corporation
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Neusoft Medical Systems Co., Ltd.
    • Esaote SpA
    • FUJIFILM Holdings Corporation
    • Samsung Electronics Co., Ltd.
Product Code: MRR-43539E5D2DD1

The Intraoperative MRI Market is projected to grow by USD 4.80 billion at a CAGR of 12.59% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.86 billion
Estimated Year [2025] USD 2.09 billion
Forecast Year [2032] USD 4.80 billion
CAGR (%) 12.59%

An authoritative overview of intraoperative MRI evolution, clinical drivers, and integration challenges shaping adoption across modern surgical programs

Intraoperative magnetic resonance imaging has transitioned from a novel adjunct to an integral tool that reshapes surgical precision and perioperative decision-making. This introduction frames the clinical, technological, and organizational drivers that have converged to accelerate adoption across specialty practices. Advances in magnet design, imaging sequences, and integration with surgical workflows are enabling teams to verify resection margins, minimize repeat procedures, and reduce complication rates while preserving function. At the same time, improvements in low-field hardware, mobility solutions, and compatibility with operative instrumentation are widening the spectrum of procedures that can incorporate real-time imaging.

Clinicians, hospital administrators, and device planners are navigating a more complex landscape where clinical efficacy must align with operational constraints and staff competencies. Reimbursement pathways and evidence generation through prospective studies are shaping institutional willingness to invest, while technology vendors are responding with modular systems and service models that emphasize workflow integration and training. Consequently, the narrative of intraoperative MRI is one of pragmatic innovation: technologies are maturing into practical solutions that address demonstrated clinical needs, yet successful deployment requires multidisciplinary alignment, robust change management, and clear measures of patient-centered value.

How technological convergence, workflow integration, and clinical evidence formation are driving a fundamental reshaping of intraoperative MRI adoption and practice

The intraoperative MRI landscape is undergoing transformative shifts driven by converging technological innovation, evolving clinical evidence, and changes in care delivery models. Recent advances in magnet engineering and imaging software have reduced the barriers to intraoperative use, enabling both high-fidelity high-field solutions and flexible low-field systems that can be accommodated in a variety of operating environments. Simultaneously, the emergence of movable and stationary system designs has created options for institutions to align capital investment with procedural volumes and facility constraints. These hardware innovations are complemented by improved imaging sequences and intraoperative protocols that enhance tissue contrast, mitigate artifacts, and shorten acquisition times, thereby making intraoperative MRI more compatible with the tempo of surgery.

Beyond hardware, workflow-centric developments-such as integration with neuronavigation platforms, instrument-tracking technologies, and intraoperative planning tools-are shifting the value proposition from image acquisition alone to comprehensive intraoperative decision support. In parallel, the clinical evidence base for intraoperative MRI, particularly in neurosurgical tumor resection and select orthopedic and oncologic applications, is solidifying. This evidence is catalyzing new care pathways that prioritize single-stage definitive procedures over staged interventions. Finally, the vendor landscape is responding with service models emphasizing training, remote support, and outcome monitoring, which further lowers implementation risk and accelerates clinician confidence in intraoperative MRI.

The ripple effects of United States tariff measures in 2025 on procurement, supply chain resilience, and operational continuity for intraoperative MRI programs

As global supply chains and trade policies evolve, tariff dynamics introduced in the United States in 2025 have become a salient factor for manufacturers, distributors, and health systems involved with intraoperative imaging solutions. These tariff measures have materially affected the sourcing calculus for core components including superconducting materials, specialized gradients, and certain electronic subsystems that are often manufactured across multiple jurisdictions. In response, suppliers have had to reassess procurement strategies, qualify alternative vendors, and in some instances redesign components to mitigate exposure to affected tariff lines. This has resulted in near-term increases in production lead times as supply chains were revalidated and dual-sourcing options were operationalized.

Clinicians and hospital procurement teams have observed the downstream effects as capital procurement cycles adjusted to account for extended lead times and revised delivery schedules. Consequently, institutions have prioritized strategic procurement planning and closer collaboration with vendors to establish guaranteed delivery windows and transparent component sourcing. At the same time, manufacturers have accelerated regionalization and in-country assembly where feasible to minimize tariff sensitivity and provide more resilient delivery commitments. These operational shifts have implications for service contracts and spare-part logistics, prompting health systems to revisit lifecycle support agreements to ensure continuity of care and minimize the risk of equipment downtime during critical surgical periods.

Segment-level insights that reveal how field strength, scanner architecture, system mobility, clinical application, and end-user setting determine technology selection and clinical workflows

A nuanced understanding of system segmentation clarifies where clinical needs intersect with technological capabilities and procurement preferences. Based on Field Strength, systems fall into high-field and low-field categories, with high-field designs delivering higher intrinsic contrast and spatial resolution that benefit complex neurosurgical resections, while low-field platforms offer reduced footprint, simpler shielding requirements, and enhanced compatibility with existing operating room infrastructures. Based on Scanner Type, the distinction between closed bore and open bore systems influences patient access and intraoperative ergonomics, where closed bore units typically provide robust image quality for head and select body procedures and open bore designs facilitate surgical access and patient monitoring during imaging.

Further segmentation by System Type differentiates movable systems from stationary systems, an important operational axis that affects capital allocation, room conversion needs, and scheduling flexibility. Movable systems present a compelling choice for facilities seeking to distribute imaging capability across multiple suites without permanent room conversion, whereas stationary systems are often selected by high-volume centers prioritizing image fidelity and integrated OR design. Based on Application, intraoperative MRI is utilized across cardiovascular, neurosurgery, oncology, and orthopedic procedures, with neurosurgery further categorized into craniotomy and spinal surgery subtypes that reflect divergent imaging and workflow requirements; oncology applications are further distinguished between biopsy guidance and tumor resection, each demanding tailored imaging sequences and intraoperative decision protocols. Finally, based on End User, adoption pathways differ between ambulatory surgical centers and hospitals, with hospitals typically investing in integrated programs that support complex, multidisciplinary cases and ambulatory centers favoring cost-effective, streamlined systems suited to high-throughput elective procedures.

Regional dynamics and infrastructure realities across the Americas, Europe Middle East & Africa, and Asia-Pacific that shape adoption pathways and support models for intraoperative MRI

Regional dynamics influence regulatory pathways, procurement behavior, and clinical adoption patterns in meaningful ways. In the Americas, established centers of neurosurgical excellence and integrated health systems have driven early adoption for complex brain tumor resections and advanced intraoperative protocols, supported by dense referral networks and concentrated research activity. This region also exhibits significant demand for modular service arrangements and financing models that align capital investment with operational throughput and clinical outcomes expectations.

In Europe, the Middle East & Africa, institutional diversity leads to heterogeneous adoption patterns: advanced tertiary centers pursue high-field stationary installations to support cutting-edge neurosurgical programs, while resource-constrained facilities assess lower-field or movable options to balance clinical benefits against infrastructure and staffing considerations. Regulatory harmonization and cross-border clinical collaborations further shape procurement decision cycles and evidence generation efforts. In the Asia-Pacific region, rapid expansion of surgical capacity, progressive hospital modernization, and targeted investments in specialty care drive interest in both movable and fixed solutions, with an emphasis on scalability, service reliability, and local support networks. Across these regions, localized training programs, reimbursement frameworks, and supply chain considerations are pivotal in determining the pace and shape of intraoperative MRI adoption.

Competitive and service-driven forces that are reshaping vendor strategies, integration models, and clinical partnerships in the intraoperative MRI ecosystem

The competitive landscape is defined by a small number of established manufacturers, emerging specialized vendors, and service providers focusing on integration, training, and lifecycle support. Established technology providers continue to leverage deep engineering expertise and clinical partnerships to extend modularity, improve imaging sequences, and offer comprehensive service packages that reduce institutional risk during deployment and operation. At the same time, specialist entrants are differentiating through design choices that emphasize mobility, reduced shielding requirements, and simplified user interfaces that lower the barrier for OR teams to adopt intraoperative imaging into routine workflows.

Service partners and systems integrators play an increasingly important role by offering project management, training, and outcome-monitoring programs that translate product capabilities into reliable clinical performance. Collaboration between vendors and clinical centers has produced standardized protocols and shared datasets that inform procedural best practices, while warranty and remote-support models are evolving to ensure uptime and rapid issue resolution. Importantly, procurement preferences reflect a balance between clinical ambition and operational pragmatism: high-volume centers prioritize image fidelity and throughput, whereas smaller facilities emphasize flexibility, total cost of ownership, and vendor responsiveness. These trends underscore the necessity for vendors to pair strong technical offerings with robust commercial and clinical support capabilities.

Actionable operational and strategic recommendations for healthcare leaders to optimize technology selection, deployment, training, and outcome measurement for intraoperative MRI

Industry leaders and hospital executives can take concrete actions to accelerate successful implementation and maximize clinical benefit from intraoperative MRI. First, align clinical stakeholders early in project planning to define case mix, workflow objectives, and training requirements so that technology selection is driven by procedural needs rather than vendor persuasion. Second, prioritize procurement strategies that incorporate lifecycle support, spare-part availability, and clearly defined service-level agreements to protect operative schedules and ensure predictable uptime. Third, consider hybrid deployment models that pair movable systems for distributed access with a centralized stationary unit for complex cases, thereby optimizing capital allocation and clinical coverage.

Fourth, invest in structured training programs and simulation-based credentialing to shorten the clinician learning curve and embed imaging protocols into routine practice. Fifth, establish outcome-monitoring frameworks that track key clinical indicators such as reoperation rates, procedure times, and patient-centered functional outcomes, and use those data to refine protocols and justify continued investment. Finally, maintain close collaboration with vendors to co-develop incremental improvements in imaging protocols, OR ergonomics, and integration with navigation and surgical planning tools, ensuring that technology evolution remains tightly coupled to clinical priorities and operational constraints.

A transparent, evidence-focused research approach integrating clinical literature, technical documentation, and stakeholder interviews to produce actionable insights for decision-makers

The research synthesis underpinning this executive summary combines a structured review of peer-reviewed clinical studies, technical white papers, regulatory filings, and vendor product documentation, complemented by qualitative interviews with clinical leads, procurement specialists, and systems integrators. Information was triangulated across multiple independent sources to develop a coherent narrative of technological trends, adoption drivers, and operational challenges. Emphasis was placed on longitudinal clinical evidence and real-world deployment experiences to ensure that insights are grounded in practical implementation realities rather than promotional statements.

Analytical rigor was applied to interpret device design attributes, workflow implications, and supply-chain vulnerabilities, with attention to variant use-cases across neurosurgery, oncology, orthopedics, and cardiovascular applications. Careful consideration was given to regional regulatory contexts and procurement practices, and sensitivity was maintained to the interplay between clinical efficacy and operational feasibility. Where direct comparative data were limited, qualitative expert judgment was used to synthesize likely programmatic outcomes, and all conclusions prioritize reproducibility and transparency in the underlying assumptions and data sources.

Synthesized conclusions highlighting the clinical value, implementation imperatives, and operational prerequisites for successful intraoperative MRI programs

In conclusion, intraoperative MRI occupies an increasingly central role in surgical programs that prioritize single-stage definitive interventions and superior tissue-sparing outcomes. Technological innovations in field strength versatility, scanner architecture, and system mobility have expanded the set of clinical settings where intraoperative imaging is practical and beneficial. At the same time, evidence maturation in key specialties has clarified where intraoperative MRI delivers measurable clinical benefits, prompting more healthcare leaders to evaluate this modality as part of strategic investments in surgical excellence.

Implementation success depends on more than device performance: it requires integrated planning across clinical teams, procurement, and service partners, as well as ongoing training and outcome measurement. Supply-chain and trade policy developments necessitate proactive procurement planning and robust vendor partnerships to ensure continuity of service. Ultimately, institutions that thoughtfully align clinical objectives with technology selection, training investments, and outcome monitoring will be best positioned to convert intraoperative MRI capability into demonstrable patient and system value.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of artificial intelligence driven real time image analysis in intraoperative MRI workflows
  • 5.2. Development of ultra high field 7 Tesla intraoperative MRI systems for improved surgical precision
  • 5.3. Expansion of portable low field intraoperative MRI units for outpatient and hybrid operating rooms
  • 5.4. Strategic collaborations between imaging device manufacturers and robotic surgery companies for integrated iMRI solutions
  • 5.5. Rising emphasis on cost effectiveness and workflow optimization in intraoperative MRI adoption and reimbursement models
  • 5.6. Regulatory approvals and safety guidelines shaping the development of novel intraoperative MRI contrast agents and protocols
  • 5.7. Emerging intraoperative MRI applications in functional neurosurgery enabling real time mapping of brain networks

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intraoperative MRI Market, by Field Strength

  • 8.1. High Field
  • 8.2. Low Field

9. Intraoperative MRI Market, by Scanner Type

  • 9.1. Closed Bore
  • 9.2. Open Bore

10. Intraoperative MRI Market, by System Type

  • 10.1. Movable Systems
  • 10.2. Stationary Systems

11. Intraoperative MRI Market, by Application

  • 11.1. Cardiovascular
  • 11.2. Neurosurgery
    • 11.2.1. Craniotomy
    • 11.2.2. Spinal Surgery
  • 11.3. Oncology
    • 11.3.1. Biopsy Guidance
    • 11.3.2. Tumor Resection
  • 11.4. Orthopedic

12. Intraoperative MRI Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals

13. Intraoperative MRI Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Intraoperative MRI Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Intraoperative MRI Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Siemens Healthineers AG
    • 16.3.2. GE HealthCare Technologies Inc.
    • 16.3.3. Koninklijke Philips N.V.
    • 16.3.4. Hitachi, Ltd.
    • 16.3.5. Canon Medical Systems Corporation
    • 16.3.6. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 16.3.7. Neusoft Medical Systems Co., Ltd.
    • 16.3.8. Esaote S.p.A.
    • 16.3.9. FUJIFILM Holdings Corporation
    • 16.3.10. Samsung Electronics Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. INTRAOPERATIVE MRI MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. INTRAOPERATIVE MRI MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. INTRAOPERATIVE MRI MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY HIGH FIELD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY HIGH FIELD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY HIGH FIELD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY HIGH FIELD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY HIGH FIELD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY HIGH FIELD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY LOW FIELD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY LOW FIELD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY LOW FIELD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY LOW FIELD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY LOW FIELD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY LOW FIELD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CLOSED BORE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CLOSED BORE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CLOSED BORE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CLOSED BORE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CLOSED BORE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CLOSED BORE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY OPEN BORE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY OPEN BORE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY OPEN BORE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY OPEN BORE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY OPEN BORE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY OPEN BORE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY MOVABLE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY MOVABLE SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY MOVABLE SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY MOVABLE SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY MOVABLE SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY MOVABLE SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY STATIONARY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY STATIONARY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY STATIONARY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY STATIONARY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY STATIONARY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY STATIONARY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CRANIOTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CRANIOTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CRANIOTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CRANIOTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CRANIOTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY CRANIOTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SPINAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SPINAL SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SPINAL SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SPINAL SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SPINAL SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY SPINAL SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY BIOPSY GUIDANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY BIOPSY GUIDANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY BIOPSY GUIDANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY BIOPSY GUIDANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY BIOPSY GUIDANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY BIOPSY GUIDANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY TUMOR RESECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY TUMOR RESECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY TUMOR RESECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY TUMOR RESECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY TUMOR RESECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY TUMOR RESECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 118. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 119. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 120. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 121. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2024 (USD MILLION)
  • TABLE 122. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2025-2032 (USD MILLION)
  • TABLE 123. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 124. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2025-2032 (USD MILLION)
  • TABLE 125. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 126. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 127. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2025-2032 (USD MILLION)
  • TABLE 129. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 131. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 132. AMERICAS INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 136. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2024 (USD MILLION)
  • TABLE 138. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2025-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 140. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2025-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 142. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2024 (USD MILLION)
  • TABLE 144. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2025-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 146. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 148. NORTH AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 152. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2025-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 156. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2025-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 158. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2024 (USD MILLION)
  • TABLE 160. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2025-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 162. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 164. LATIN AMERICA INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2025-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 200. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 204. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2025-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2024 (USD MILLION)
  • TABLE 208. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2025-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 210. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 212. MIDDLE EAST INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 213. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 216. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 217. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 223. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2024 (USD MILLION)
  • TABLE 224. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2025-2032 (USD MILLION)
  • TABLE 225. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 226. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 227. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 228. AFRICA INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2024 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2025-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 247. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 250. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 251. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2025-2032 (USD MILLION)
  • TABLE 253. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 256. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 257. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2024 (USD MILLION)
  • TABLE 258. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2025-2032 (USD MILLION)
  • TABLE 259. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 260. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 261. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. ASEAN INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. GCC INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. GCC INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. GCC INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 266. GCC INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 267. GCC INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. GCC INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. GCC INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. GCC INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. GCC INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. GCC INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 273. GCC INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2024 (USD MILLION)
  • TABLE 274. GCC INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2025-2032 (USD MILLION)
  • TABLE 275. GCC INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 276. GCC INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 277. GCC INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 278. GCC INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPEAN UNION INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 295. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 296. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 297. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 298. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 299. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 304. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 305. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2024 (USD MILLION)
  • TABLE 306. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2025-2032 (USD MILLION)
  • TABLE 307. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 308. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 309. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 310. BRICS INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 311. G7 INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 312. G7 INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 313. G7 INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 314. G7 INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 315. G7 INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. G7 INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. G7 INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 318. G7 INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2025-2032 (USD MILLION)
  • TABLE 319. G7 INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 320. G7 INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 321. G7 INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2024 (USD MILLION)
  • TABLE 322. G7 INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2025-2032 (USD MILLION)
  • TABLE 323. G7 INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 324. G7 INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 325. G7 INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 326. G7 INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 327. NATO INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 328. NATO INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 329. NATO INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 330. NATO INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 331. NATO INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2018-2024 (USD MILLION)
  • TABLE 332. NATO INTRAOPERATIVE MRI MARKET SIZE, BY SCANNER TYPE, 2025-2032 (USD MILLION)
  • TABLE 333. NATO INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 334. NATO INTRAOPERATIVE MRI MARKET SIZE, BY SYSTEM TYPE, 2025-2032 (USD MILLION)
  • TABLE 335. NATO INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 336. NATO INTRAOPERATIVE MRI MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 337. NATO INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2018-2024 (USD MILLION)
  • TABLE 338. NATO INTRAOPERATIVE MRI MARKET SIZE, BY NEUROSURGERY, 2025-2032 (USD MILLION)
  • TABLE 339. NATO INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 340. NATO INTRAOPERATIVE MRI MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 341. NATO INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 342. NATO INTRAOPERATIVE MRI MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 343. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 344. GLOBAL INTRAOPERATIVE MRI MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 345. UNITED STATES INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 346. UNITED STATES INTRAOPERATIVE MRI MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)